Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy

Executive Summary

Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy

You may also be interested in...



Peer-Reviewed Uncontrolled Trials Valid For Drug Promotions, WLF Says

Uncontrolled studies published in peer-reviewed journals should be acceptable as promotional information if disseminated with an FDA disclaimer, the Washington Legal Foundation said during FDA's public hearing on direct-to-consumer advertising Nov. 1-2

Peer-Reviewed Uncontrolled Trials Valid For Drug Promotions, WLF Says

Uncontrolled studies published in peer-reviewed journals should be acceptable as promotional information if disseminated with an FDA disclaimer, the Washington Legal Foundation said during FDA's public hearing on direct-to-consumer advertising Nov. 1-2

PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007

PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS046336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel